NHC · National Healthcare Corp
$236.01
-7.06 (-2.90%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$3.70B
Shares
15.66M
Volume · Oct 23
192.99K
Avg daily vol (3M)
109.17K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$236.01
Open$242.78
Day$235.49–243.52
52W close$119.44–247.94
Avg vol 30d114K
Short int817K · 5.2% float · 6.2d
Short vol75%
DataJan 2020–Oct 2026
Filing10-Q · Aug 6
Up next
filed Aug 6, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$1.56B
Trailing 12 months
Net income (TTM)
$140.18M
Trailing 12 months
Revenue growth YoY
+8.8%
Year over year
Operating margin
9.3%
Trailing 12 months
P / E (TTM)
26.5
Trailing earnings · reciprocal yield 3.8%
FCF yield
4.0%
TTM · current market cap
Return on invested capital
10.3%
Trailing 12 months
Net cash
$39.21M
Latest balance sheet
Dividend yield
1.1%
Trailing 12 months
Shares change YoY
+1.7%
Year over year · more shares
Price change (1Y)
+93.3%
Trailing year
Short interest
5.2%
Latest settlement · 6.2 days to cover
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceOverall
Strong Buy
SellHoldBuy
Technical
Strong Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
Low
Market backdrop
VIX 19.5 · elevated
Equity put/call 0.67
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+23%
above
Price vs 50-day avg
+4%
above
RSI (14)
53
neutral
MACD trend
Positive
52-week position
91%
near high
Momentum
relative strength
1-month return
+4%
trailing
6-month return
+38%
trailing
YTD return
+72%
this year
Relative strength
+32%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $228 › 200d $192 — 50d above 200d
Institutional flow
Accumulating
51 of 252 funds reported for Sep 30 · net +17.2K sh shares · +10 new
Insider flow
Distributing
Net -$5.6M over 90 days · 100% sells
Short interest
Rising
5.22% of float · ▲ +19.6% MoM · 6.2 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr high
252 holders — near 3-yr high, broad support
Squeeze score
69
elevated · 0–100
Fundamentals
Revenue growth
+16%
Y/Y
EPS growth
+17%
Y/Y
Free cash flow
$148.6M
Valuation
P/E 26.6
rich
Buyback
$25.0M
authorized
Balance sheet
$52.8M
net cash
Quant / Vol
risk profile
Volatility
34%
annualized · 1-yr
Max drawdown
−10%
past year
ATR
3.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+23%
Bullish
Price vs 50-day avg
+4%
Bullish
RSI (14)
53
Neutral
MACD trend
Positive
Bullish
52-week position
91%
Bullish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $228 › 200d $192 — 50d above 200d
Institutional flow
Accumulating
51 of 252 funds reported for Sep 30 · net +17.2K sh shares · +10 new
Insider flow
Distributing
Net -$5.6M over 90 days · 100% sells
Short interest
Rising
5.22% of float · ▲ +19.6% MoM · 6.2 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr high
252 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $119
Now $236 · 91%
Range high $248
vs 200-day avg +23%
vs 50-day avg +4%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted diluted earnings per share non-GAAP | $1.74 | Q2 FY2026 | — |
| assisted living communities | 26 | As of August 1, 2026 | — |
| assisted living units | 1,413 | As of August 1, 2026 | — |
| Average Skilled Nursing Per Diem | $366.88 | Q2 FY2026 | — |
| homecare agencies | 34 | As of August 1, 2026 | — |
| hospice agencies | 33 | As of August 1, 2026 | — |
| independent living units | 775 | As of August 1, 2026 | — |
| Non-GAAP Net income non-GAAP | 27.55M | Q2 FY2026 | — |
GAAP → non-GAAP reconciliationGAAP Net income attributable to National Healthcare Corporation 40.32M
-915K Unrealized gains on marketable equity securities
+1.99M Stock-based compensation expense
+0K Gain on sale of property and equipment
-278K Income tax provision on non-GAAP adjustments
= Non-GAAP Net income 41.11M
|
|||
| skilled nursing beds | 10,323 | As of August 1, 2026 | — |
| skilled nursing facilities | 80 | As of August 1, 2026 | — |
| Total Skilled Nursing Patient Days | 749,723 | Q2 FY2026 | — |
| overall census in owned and leased skilled nursing facilities | 90.1% | the three months ending June 30, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NHC
this stock
National Healthcare Corp
|
$3.70B | +72.2% | +16.1% | 26.6 | 5.2% |
|
HCA
HCA Healthcare, Inc.
|
$104.05B | +0.5% | +7.1% | 15.7 | 2.2% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$29.02B | -10.1% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$21.62B | +35.1% | +0.9% | 10.4 | 2.3% |
|
EHC
Encompass Health Corp
|
$12.24B | +16.9% | +10.5% | 20.2 | 3.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NHC | -2.8% | +3.8% | +38.3% | +7.5% | +72.2% |
| SPY | -0.4% | -1.5% | +5.8% | -0.4% | +11.5% |
| vs SPY | -2.4% | +5.3% | +32.5% | +7.9% | +60.7% |
Capital returns
Latest dividend
$0.67
/ share · ex Sep 30, 2026
Paid (TTM)
$2.62
/ share · 4 payouts
Dividend yield (TTM, derived)
1.11%
Buyback program
· as of Aug 31, 2019
Authorized
$25.00M
Spent (derived)
—
Remaining
—
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
Key facts
CIK
1047335
CUSIP
635906100
13F (30d)
51 filings
51 filers
Visit website
Investor relations